Atlas Trials

Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute

Clinical trial NCT03057483 · COMPLETED

Trial details

NCT number
NCT03057483
Sponsor
Butantan Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Influenza Vaccines
Start date
2017-04-06
Primary completion
2017-09-06
Enrollment
533

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.